nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.211	0.476	CbGbCtD
Zopiclone—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.147	0.332	CbGbCtD
Zopiclone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0857	0.193	CbGbCtD
Zopiclone—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0323	0.0581	CcSEcCtD
Zopiclone—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0185	0.0334	CcSEcCtD
Zopiclone—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0307	CcSEcCtD
Zopiclone—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0307	CcSEcCtD
Zopiclone—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0241	CcSEcCtD
Zopiclone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0201	CcSEcCtD
Zopiclone—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0201	CcSEcCtD
Zopiclone—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00969	0.0174	CcSEcCtD
Zopiclone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00924	0.0166	CcSEcCtD
Zopiclone—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00899	0.0162	CcSEcCtD
Zopiclone—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00891	0.016	CcSEcCtD
Zopiclone—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.0086	0.0155	CcSEcCtD
Zopiclone—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00825	0.0149	CcSEcCtD
Zopiclone—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00806	0.0145	CcSEcCtD
Zopiclone—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0077	0.0139	CcSEcCtD
Zopiclone—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00742	0.0134	CcSEcCtD
Zopiclone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.0133	CcSEcCtD
Zopiclone—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00722	0.013	CcSEcCtD
Zopiclone—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.0129	CcSEcCtD
Zopiclone—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.0129	CcSEcCtD
Zopiclone—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.0128	CcSEcCtD
Zopiclone—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.0128	CcSEcCtD
Zopiclone—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.0128	CcSEcCtD
Zopiclone—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00694	0.0125	CcSEcCtD
Zopiclone—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.0117	CcSEcCtD
Zopiclone—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.0117	CcSEcCtD
Zopiclone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00625	0.0113	CcSEcCtD
Zopiclone—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00625	0.0113	CcSEcCtD
Zopiclone—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.011	CcSEcCtD
Zopiclone—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00595	0.0107	CcSEcCtD
Zopiclone—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0104	CcSEcCtD
Zopiclone—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00562	0.0101	CcSEcCtD
Zopiclone—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00551	0.00992	CcSEcCtD
Zopiclone—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00942	CcSEcCtD
Zopiclone—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.00921	CcSEcCtD
Zopiclone—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00507	0.00913	CcSEcCtD
Zopiclone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.00901	CcSEcCtD
Zopiclone—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00886	CcSEcCtD
Zopiclone—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00871	CcSEcCtD
Zopiclone—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.00847	CcSEcCtD
Zopiclone—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0084	CcSEcCtD
Zopiclone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00833	CcSEcCtD
Zopiclone—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00833	CcSEcCtD
Zopiclone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00802	CcSEcCtD
Zopiclone—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.00776	CcSEcCtD
Zopiclone—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00423	0.00762	CcSEcCtD
Zopiclone—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.00749	CcSEcCtD
Zopiclone—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.00747	CcSEcCtD
Zopiclone—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.00732	CcSEcCtD
Zopiclone—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00704	CcSEcCtD
Zopiclone—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00684	CcSEcCtD
Zopiclone—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00676	CcSEcCtD
Zopiclone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.00666	CcSEcCtD
Zopiclone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.00662	CcSEcCtD
Zopiclone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00651	CcSEcCtD
Zopiclone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.0064	CcSEcCtD
Zopiclone—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00636	CcSEcCtD
Zopiclone—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.00634	CcSEcCtD
Zopiclone—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.00634	CcSEcCtD
Zopiclone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.00622	CcSEcCtD
Zopiclone—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.00615	CcSEcCtD
Zopiclone—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00326	0.00587	CcSEcCtD
Zopiclone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00586	CcSEcCtD
Zopiclone—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00583	CcSEcCtD
Zopiclone—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00581	CcSEcCtD
Zopiclone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00546	CcSEcCtD
Zopiclone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00526	CcSEcCtD
Zopiclone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00518	CcSEcCtD
Zopiclone—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.005	CcSEcCtD
Zopiclone—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00499	CcSEcCtD
Zopiclone—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00495	CcSEcCtD
Zopiclone—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.0049	CcSEcCtD
Zopiclone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.0048	CcSEcCtD
Zopiclone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00478	CcSEcCtD
Zopiclone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00473	CcSEcCtD
Zopiclone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00471	CcSEcCtD
Zopiclone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00469	CcSEcCtD
Zopiclone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00466	CcSEcCtD
Zopiclone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.0046	CcSEcCtD
Zopiclone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00458	CcSEcCtD
Zopiclone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00442	CcSEcCtD
Zopiclone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0044	CcSEcCtD
Zopiclone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00434	CcSEcCtD
Zopiclone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00434	CcSEcCtD
Zopiclone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00433	CcSEcCtD
Zopiclone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00429	CcSEcCtD
Zopiclone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00425	CcSEcCtD
Zopiclone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0042	CcSEcCtD
Zopiclone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00416	CcSEcCtD
Zopiclone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00413	CcSEcCtD
Zopiclone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00402	CcSEcCtD
Zopiclone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00397	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00379	CcSEcCtD
Zopiclone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00376	CcSEcCtD
Zopiclone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00374	CcSEcCtD
Zopiclone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00371	CcSEcCtD
Zopiclone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0037	CcSEcCtD
Zopiclone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00366	CcSEcCtD
Zopiclone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00362	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00359	CcSEcCtD
Zopiclone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00359	CcSEcCtD
Zopiclone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00356	CcSEcCtD
Zopiclone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00356	CcSEcCtD
Zopiclone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00343	CcSEcCtD
Zopiclone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0034	CcSEcCtD
Zopiclone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00331	CcSEcCtD
Zopiclone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00329	CcSEcCtD
Zopiclone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00329	CcSEcCtD
Zopiclone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00307	CcSEcCtD
Zopiclone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00299	CcSEcCtD
Zopiclone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00294	CcSEcCtD
Zopiclone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00285	CcSEcCtD
Zopiclone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00275	CcSEcCtD
Zopiclone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00265	CcSEcCtD
Zopiclone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00262	CcSEcCtD
Zopiclone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00262	CcSEcCtD
Zopiclone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00261	CcSEcCtD
Zopiclone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00247	CcSEcCtD
